|

Amivantamab IV Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since May 2026

Also known as: JNJ-61186372, RYBREVANT

Pipeline

Phase 1/2: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Advanced or Metastatic Colorectal Cancer1
  • Cancer1

Birmingham, Alabama1 trial

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

O Neal Comprehensive Cancer Center at UAB

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.